NASDAQ : IMA
ImageneBio, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 4.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 46.54M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 46.43M |
| Enterprise Value | -87.81M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 11.35M |
| Shares Outstanding | 11.35M |
| Shares Change (YoY) | -97.61% |
| Shares Change (QoQ) | +44.16% |
| Owned by Insiders (%) | 2.06% |
| Owned by Institutions (%) | 27.86% |
| Float | 5.83M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 21.47 |
| Quick Ratio | 20.71 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -82.68% |
| Return on Assets (ROA) | -43.06% |
| Return on Invested Capital (ROIC) | -48.44% |
| Return on Capital Employed (ROCE) | -40.53% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.96M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -324,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -53.04% |
| 50-Day Moving Average | 4.64 |
| 200-Day Moving Average | 5.62 |
| Relative Strength Index (RSI) | 39.98 |
| Average Volume (20 Days) | 13,655 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 61,349 |
| Short Previous Month | 32,852 |
| Short % of Shares Out | 0.54% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 3.80 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -58.96M |
| Pretax Income | -52.81M |
| Net Income | -53.33M |
| EBITDA | -58.37M |
| EBIT | -58.96M |
| Earnings Per Share (EPS) | -$4.81 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 136.15M |
| Total Debt | 1.91M |
| Net Cash | 134.24M |
| Net Cash Per Share | $11.83 |
| Equity (Book Value) | 142.07M |
| Book Value Per Share | 12.60 |
| Working Capital | 134.54M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -52.59M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 594,500 |
| Net Borrowing | n/a |
| Free Cash Flow | -52.59M |
| FCF Per Share | -$4.63 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 97.61% |
| Shareholder Yield | 97.61% |
| Earnings Yield | -117.69% |
| FCF Yield | -112.99% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $18.00 |
| Price Target Difference | 340.10% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |